Delivery Order SPE2DB20D2104-SPE2DB23FT32R
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,374.91, is a delivery order for the pharmaceutical product MOVANTIK 25 MG TABLET 30S. The award has an ultimate completion date of October 30, 2023 and is a firm fixed-price contract. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price of $1,405.17 and a period of performance through February 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, with a ceiling value of $5,397.18, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. The award is not designated under any set-aside program, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Movantik 25 mg tablets. The award, valued at $4,832.18, was made by the Defense Logistics Agency (DLA) Troop Support Medical on December 7, 2023, with a completion date of December 8, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,017.58 for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a completion date of February 24, 2025 and is a Firm Fixed Price arrangement. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,566.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,956.67 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET UD 100S, a pharmaceutical product, with a completion date of January 29, 2024. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a firm fixed price of $1,177.53 and a completion date of June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides...
- This federal contract award is for the delivery of Movantik 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a ceiling value of $2,202.06 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,045.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of MOVANTIK 25 MG TABLET UD 100S. This contract has an ultimate completion date of September 30, 2024 and is not a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT32RDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOVANTIK 25 MG TABLET 30S. The contract, valued at $1,951.24, is a delivery order that runs through May 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating it was awarded through full and open competition. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/2/23 |